BAY60-4552
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BAY60-4552, covering 2013-02-22 to 2014-11-04. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Proof-of-concept Study for the Combination BAY60-4552 / Vardenafil for the Treatment of Erectile Dysfunction Not Sufficiently Responsive to Standard Therapy With PDE5 Inhibitors [Phase 2]